Cargando…
Repositioning Glucagon Action in the Physiology and Pharmacology of Diabetes
Glucagon is historically described as the counterregulatory hormone to insulin, induced by fasting/hypoglycemia to raise blood glucose through action mediated in the liver. However, it is becoming clear that the biology of glucagon is much more complex and extends beyond hepatic actions to exert con...
Autores principales: | Finan, Brian, Capozzi, Megan E., Campbell, Jonathan E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7085250/ https://www.ncbi.nlm.nih.gov/pubmed/31178432 http://dx.doi.org/10.2337/dbi19-0004 |
Ejemplares similares
-
Targeting the Incretin/Glucagon System With Triagonists to Treat Diabetes
por: Capozzi, Megan E, et al.
Publicado: (2018) -
Repositioning the Alpha Cell in Postprandial Metabolism
por: El, Kimberley, et al.
Publicado: (2020) -
The Local Paracrine Actions of the Pancreatic α-Cell
por: Rodriguez-Diaz, Rayner, et al.
Publicado: (2020) -
Defining Heterogeneity Among Women With Gestational Diabetes Mellitus
por: Powe, Camille E., et al.
Publicado: (2020) -
Persistent Effects of Intensive Glycemic Control on Retinopathy in Type 2 Diabetes in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Follow-On Study
Publicado: (2016)